Post-IPO Equity - Alere
Investment Firm
Overview
Alere provides diagnostics and health management solutions for infectious, heart and cancer-related diseases and drug addicts.
Announced Date
Aug 14, 2017
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Alere raised an undisclosed amount on 2017-08-14 in Post-IPO Equity
Alere provides diagnostics and health management solutions for infectious, heart and cancer-related diseases and drug addicts.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 30, 2003 |  Venture Round - Alere | 4 | - | 5.1M |
| Aug 14, 2017 | Post-IPO Equity - Alere | 1 | - | undefined |
| Oct 13, 2009 | Debt Financing - Alere | - | 100.0M | |
| Sep 21, 2010 | Post-IPO Debt - Alere | - | 400.0M |
Recent Activity
There is no recent news or activity for this profile.